Cargando…

Prediction of mechanistic subtypes of Parkinson’s using patient-derived stem cell models

Parkinson’s disease is a common, incurable neurodegenerative disorder that is clinically heterogeneous: it is likely that different cellular mechanisms drive the pathology in different individuals. So far it has not been possible to define the cellular mechanism underlying the neurodegenerative dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Sa, Karishma, Evans, James R., Virdi, Gurvir S., Vecchi, Giulia, Adam, Alexander, Bertolli, Ottavia, Fleming, James, Chang, Hojong, Leighton, Craig, Horrocks, Mathew H., Athauda, Dilan, Choi, Minee L., Gandhi, Sonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442231/ https://www.ncbi.nlm.nih.gov/pubmed/37615030 http://dx.doi.org/10.1038/s42256-023-00702-9

Ejemplares similares

The Impact of Type 2 Diabetes in Parkinson's Disease
por: Athauda, Dilan, et al.
Publicado: (2022)

Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons
por: Virdi, Gurvir S., et al.
Publicado: (2022)

Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity
por: Choi, Minee L., et al.
Publicado: (2022)

Author Correction: Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity
por: Choi, Minee L., et al.
Publicado: (2022)

Nanoscopic Characterisation of Individual Endogenous Protein Aggregates in Human Neuronal Cells
por: Whiten, Daniel R., et al.
Publicado: (2018)

Technologies Assessing Limb Bradykinesia in Parkinson’s Disease
por: Hasan, Hasan, et al.
Publicado: (2017)

Diabetes and Neuroaxonal Damage in Parkinson's Disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

Commentary: “Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: a systematic review and meta-analysis”
por: Lawton, Michael, et al.
Publicado: (2023)

Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes
por: Brauer, Ruth, et al.
Publicado: (2020)

High Grade Glioma Mimicking Voltage Gated Potassium Channel Complex Associated Antibody Limbic Encephalitis
por: Athauda, Dilan, et al.
Publicado: (2014)

Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
por: Toomey, Christina E., et al.
Publicado: (2022)

α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease
por: Ludtmann, Marthe H. R., et al.
Publicado: (2018)

Effect of the magnetic field on positron range using GATE for PET-MR
por: Eleftheriou, Afroditi, et al.
Publicado: (2014)

Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis
por: Hughes, Craig D., et al.
Publicado: (2018)

Mechanistic Insights into Selective Autophagy Subtypes in Alzheimer’s Disease
por: Guan, Xinjie, et al.
Publicado: (2022)

Lipid peroxidation is essential for α‐synuclein‐induced cell death
por: Angelova, Plamena R., et al.
Publicado: (2015)

Iterative reconstruction incorporating positron range correction within STIR framework
por: Bertolli, Ottavia, et al.
Publicado: (2014)

A mechanistic model of tau amyloid aggregation based on direct observation of oligomers
por: Shammas, Sarah L., et al.
Publicado: (2015)

212 Skills Learned during Critical Care Prospective Audit and Feedback are Utilized outside of the Stewardship Environment
por: Ali, Karim, et al.
Publicado: (2014)

When Antimicrobial Stewardship Isn′t Watching: The Educational Impact of Critical Care Prospective Audit and Feedback
por: Fleming, Dimitra, et al.
Publicado: (2016)

Parkinson’s Disease Subtypes: Critical Appraisal and Recommendations
por: Mestre, Tiago A., et al.
Publicado: (2021)

Combining biomarkers for prognostic modelling of Parkinson’s disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation
por: Angelova, Plamena R., et al.
Publicado: (2020)

Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease
por: Deas, Emma, et al.
Publicado: (2016)

Is there a subtype of developmental Parkinson's disease?
por: Riederer, P.
Publicado: (2003)

Nanobodies raised against monomeric ɑ-synuclein inhibit fibril formation and destabilize toxic oligomeric species
por: Iljina, Marija, et al.
Publicado: (2017)

Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing
por: Ullah, Hammad, et al.
Publicado: (2018)

Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy
por: Gao, Xiao-Yan, et al.
Publicado: (2022)

Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance
por: Kwon, So Mee, et al.
Publicado: (2015)

Subtypes and Mechanistic Advances of Extracorporeal Membrane Oxygenation-Related Acute Brain Injury
por: Deng, Bixin, et al.
Publicado: (2023)

Vasa vitae--keeping the channels open.
por: D'Sa, A. A.
Publicado: (1998)

Arachidonic acid mediates the formation of abundant alpha-helical multimers of alpha-synuclein
por: Iljina, Marija, et al.
Publicado: (2016)

Neural and behavioral substrates of subtypes of Parkinson’s disease
por: Moustafa, Ahmed A., et al.
Publicado: (2013)

Clinical Markers of Anxiety Subtypes in Parkinson Disease
por: Broen, Martinus P. G., et al.
Publicado: (2018)

Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
por: Schneider, Susanne A., et al.
Publicado: (2020)

Subtyping of Parkinson’s Disease - Where Are We Up To?
por: Qian, Elizabeth, et al.
Publicado: (2019)

Assessment of Force Production in Parkinson’s Disease Subtypes
por: Pelicioni, Paulo Henrique Silva, et al.
Publicado: (2021)

Characterization of Parkinson's Disease Subtypes and Related Attributes
por: Shakya, Shamatree, et al.
Publicado: (2022)

Biomarker characterization of clinical subtypes of Parkinson Disease
por: Deng, Xiao, et al.
Publicado: (2022)

Precision medicine for Parkinson’s disease: The subtyping challenge
por: Frasier, Mark, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g14o4h4sa4dtgt5lfjaasc3gnk